Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

Nature

Volumn 390, Issue 6658, 1997, Pages 404-407

  Boehm, T ^a   Folkman, J ^a   Browder, T ^a   O'Reilly, M S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL NEOPLASM; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; COLLAGEN; CYCLOPHOSPHAMIDE; DRUG RESISTANCE, NEOPLASM; ENDOSTATINS; FIBROSARCOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS;

ANIMALIA;

EID: 0031469819     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/37126     Document Type: Article

References (13)